Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance.

Hyun SJ, Sohn HJ, Lee HJ, Lee SD, Kim S, Sohn DH, Hong CH, Choi H, Cho HI, Kim TG.

Front Immunol. 2017 Nov 21;8:1591. doi: 10.3389/fimmu.2017.01591. eCollection 2017.

2.

Human CD8+ CD57- TEMRA cells: Too young to be called "old".

Verma K, Ogonek J, Varanasi PR, Luther S, Bünting I, Thomay K, Behrens YL, Mischak-Weissinger E, Hambach L.

PLoS One. 2017 May 8;12(5):e0177405. doi: 10.1371/journal.pone.0177405. eCollection 2017.

3.

CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies.

Smith CJ, Quinn M, Snyder CM.

Front Immunol. 2016 Sep 15;7:352. eCollection 2016. Review.

4.

CMV-specific immune reconstitution following allogeneic stem cell transplantation.

Blyth E, Withers B, Clancy L, Gottlieb D.

Virulence. 2016 Nov 16;7(8):967-980. Epub 2016 Aug 9. Review.

5.

Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission.

Yoon JH, Lee S, Kim HJ, Jeon YW, Lee SE, Cho BS, Lee DG, Eom KS, Kim YJ, Min CK, Cho SG, Min WS, Lee JW.

Oncotarget. 2016 Mar 29;7(13):17230-41. doi: 10.18632/oncotarget.7347.

6.

Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.

Link CS, Eugster A, Heidenreich F, Rücker-Braun E, Schmiedgen M, Oelschlägel U, Kühn D, Dietz S, Fuchs Y, Dahl A, Domingues AM, Klesse C, Schmitz M, Ehninger G, Bornhäuser M, Schetelig J, Bonifacio E.

Clin Exp Immunol. 2016 Jun;184(3):389-402. doi: 10.1111/cei.12770. Epub 2016 Mar 8.

7.

Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.

Quinn M, Erkes DA, Snyder CM.

Immunotherapy. 2016 Feb;8(2):211-21. doi: 10.2217/imt.15.110. Epub 2016 Jan 20. Review.

8.

Trypanosoma-Cruzi Cross-Reactive Antibodies Longitudinal Follow-Up: A Prospective Observational Study in Hematopoietic Stem Cell Transplantation.

Saba ES, Gueyffier L, Danjoy ML, Vanhems P, Pozzetto B, Sobh M, Pottel H, Michallet M, Zrein MA.

PLoS One. 2015 Sep 9;10(9):e0137240. doi: 10.1371/journal.pone.0137240. eCollection 2015.

9.

Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral blood.

Beloki L, Ciaurriz M, Mansilla C, Zabalza A, Perez-Valderrama E, Samuel ER, Lowdell MW, Ramirez N, Olavarria E.

J Transl Med. 2015 May 20;13:165. doi: 10.1186/s12967-015-0515-z.

10.

Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.

Roberto A, Castagna L, Zanon V, Bramanti S, Crocchiolo R, McLaren JE, Gandolfi S, Tentorio P, Sarina B, Timofeeva I, Santoro A, Carlo-Stella C, Bruno B, Carniti C, Corradini P, Gostick E, Ladell K, Price DA, Roederer M, Mavilio D, Lugli E.

Blood. 2015 Apr 30;125(18):2855-64. doi: 10.1182/blood-2014-11-608406. Epub 2015 Mar 5.

11.

Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.

Quinn M, Turula H, Tandon M, Deslouches B, Moghbeli T, Snyder CM.

J Immunol. 2015 Feb 15;194(4):1726-1736. doi: 10.4049/jimmunol.1402757. Epub 2015 Jan 16.

12.

Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effects.

Fuji S, Kapp M, Einsele H.

Front Immunol. 2013 Oct 14;4:330. doi: 10.3389/fimmu.2013.00330. Review.

13.

Clinical factors influencing phenotype of HCMV-specific CD8+ T cells and HCMV-induced interferon-gamma production after allogeneic stem cells transplantation.

Gayoso I, Cantisán S, Cerrato C, Sánchez-García J, Martin C, Solana R, Torres-Gomez A, Torre-Cisneros J.

Clin Dev Immunol. 2013;2013:347213. doi: 10.1155/2013/347213. Epub 2013 Feb 2.

14.

A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory.

Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, Douek DC, Fahle GH, Cohen JI, Holland SM, Milner JD.

Immunity. 2011 Nov 23;35(5):806-18. doi: 10.1016/j.immuni.2011.09.016.

15.

Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.

Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF.

J Infect Dis. 2011 Dec 1;204(11):1663-71. doi: 10.1093/infdis/jir624. Epub 2011 Oct 21.

16.

CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Strioga M, Pasukoniene V, Characiejus D.

Immunology. 2011 Sep;134(1):17-32. doi: 10.1111/j.1365-2567.2011.03470.x. Epub 2011 Jun 29. Review.

17.

Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.

McIver ZA, Melenhorst JJ, Grim A, Naguib N, Weber G, Fellowes V, Khuu H, Stroncek DS, Leitman SF, Battiwalla M, Barrett AJ.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1846-54. doi: 10.1016/j.bbmt.2011.05.017. Epub 2011 May 30.

18.

Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.

Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, Kadidlo DM, McKenna DH, Bromberg JS, Levine BL, Riley JL, June CH, Scheinberg P, Douek DC, Miller JS, Wagner JE, Blazar BR.

Sci Transl Med. 2011 May 18;3(83):83ra41. doi: 10.1126/scitranslmed.3001809.

19.

Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Melenhorst JJ, Scheinberg P, Williams A, Ambrozak DR, Keyvanfar K, Smith M, McCoy JP Jr, Hensel NF, Douek DC, Barrett AJ.

Biol Blood Marrow Transplant. 2011 Jun;17(6):800-9. doi: 10.1016/j.bbmt.2010.12.711. Epub 2011 Jan 6.

20.

T cells engineered with a cytomegalovirus-specific chimeric immunoreceptor.

Full F, Lehner M, Thonn V, Goetz G, Scholz B, Kaufmann KB, Mach M, Abken H, Holter W, Ensser A.

J Virol. 2010 Apr;84(8):4083-8. doi: 10.1128/JVI.02117-09. Epub 2010 Feb 10.

Supplemental Content

Support Center